Home / C1-Inhibitor, plasma derived / Czechia
CZ ATC B06AC01 · updated 2 Nov 2026
C1-Inhibitor, plasma derived shortage in Czechia
Is there a C1-Inhibitor, plasma derived shortage in Czechia?
Yes. As of 2 Nov 2026, 1 C1-Inhibitor, plasma derived product is reported short in Czechia, the first since 19 Aug 2025. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | BERINERT 3000IU 3000IU INJ PSO LQF 5+5X5,6ML | CSL Behring GmbH, Marburg | 19 Aug 2025 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.